| |
| |
Note |
Year ended
2 January
2010
$ million |
Restated*
Year ended
3 January
2009
$ million |
Restated*
Year ended
29 December
2007
$ million |
| |
|
|
|
| Sales |
4 |
4,180.1 |
5,515.9 |
5,886.1 |
| Cost of sales |
|
(2,995.9) |
(4,023.7) |
(4,284.6) |
| Gross profit |
|
1,184.2 |
1,492.2 |
1,601.5 |
| Distribution costs |
|
(464.8) |
(584.5) |
(578.4) |
| Administrative expenses |
|
(480.4) |
(513.3) |
(500.9) |
| Impairments |
5 |
(73.0) |
(342.4) |
(0.8) |
| Restructuring costs |
6 |
(144.1) |
(26.0) |
(27.6) |
| Net gain on disposals and on the exit of businesses |
6 |
0.2 |
43.0 |
91.4 |
| Gain on amendment of post-employment benefits |
7 |
63.0 |
– |
– |
| Share of (loss)/profit of associates |
22 |
(0.4) |
(2.1) |
0.8 |
| Operating profit |
|
84.7 |
66.9 |
586.0 |
| |
|
|
|
|
| Interest payable |
9 |
(113.2) |
(137.8) |
(142.1) |
| Investment income |
10 |
67.2 |
87.8 |
86.8 |
| Other finance expense |
11 |
(0.3) |
(25.0) |
(5.6) |
| Net finance costs |
|
(46.3) |
(75.0) |
(60.9) |
| Profit/(loss) before tax |
|
38.4 |
(8.1) |
525.1 |
| Income tax expense |
12 |
(28.5) |
(38.4) |
(139.9) |
| Profit/(loss) for the period from continuing operations |
|
9.9 |
(46.5) |
385.2 |
| |
|
|
|
|
|
|
|
|
| Loss for the period from discontinued operations |
13 |
(3.9) |
– |
(66.7) |
| Profit/(loss) for the period |
14 |
6.0 |
(46.5) |
318.5 |
| Minority interests |
|
(21.6) |
(18.1) |
(25.0) |
| (Loss)/profit for the period attributable to equity shareholders |
|
(15.6) |
(64.6) |
293.5 |
| |
|
|
|
|
|
|
|
|
| Basic |
|
|
|
|
| Continuing operations |
|
(1.33)c |
(7.34)c |
41.38 c |
| Discontinued operations |
|
(0.44)c |
– c |
(7.66)c |
| Total operations |
15 |
(1.77)c |
(7.34)c |
33.72 c |
| |
|
|
|
|
| Diluted |
|
|
|
|
| Continuing operations |
|
(1.33)c |
(7.34)c |
40.88 c |
| Discontinued operations |
|
(0.44)c |
– c |
(7.54)c |
| Total operations |
15 |
(1.77)c |
(7.34)c |
33.34 c |
| |
|
|
|
|
| Dividends per ordinary share |
16 |
10.00 c |
13.02 c |
27.68 c |
* See note 2 |
